ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE |
SECURITIES EXCHANGE ACT OF 1934 |
Florida | 65-0701248 | |
(State or other jurisdiction of | (I.R.S. Employer | |
incorporation or organization) | Identification Number) |
4400 Biscayne Boulevard, 12th Floor | ||
Miami, Florida | 33137 | |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Name of each exchange on which registered | |
Common stock, par value $.0001 per share | NYSE Amex |
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting companyþ | |||
(Do not check if a smaller reporting company) |
2
3
ITEM 10. | DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. |
Henry C. Beinstein, 67
Director since 2001 |
Mr. Beinstein has been a director of Vector Group Ltd., a New York Stock Exchange listed holding company, since 1994. Vector Group is engaged principally in the tobacco business through its Liggett Group LLC subsidiary and in the real estate and investment business through its New Valley LLC subsidiary. New Valley owns 50% of Douglas Elliman Realty, LLC, which operates the largest residential brokerage company in the New York metropolitan area. Mr. Beinstein has been a director of Castle Brands Inc., an NYSE Amex listed company which markets and imports premium spirits, since January 2009. Since January 2005, Mr. Beinstein has been a partner of Gagnon Securities, LLC, a broker-dealer and a FINRA member firm, and has been a money manager and an analyst and registered representative of such firm since August 2002. Mr. Beinstein retired in August 2002 as the executive director of Schulte Roth & Zabel LLP, a New York-based law firm, a position he had held since August 1997. Before that, Mr. Beinstein had served as the managing director of Milbank, Tweed, Hadley & McCloy LLP, a New York-based law firm, commencing in November 1995. From April 1985 through October 1995, Mr. Beinstein was the executive director of Proskauer Rose LLP, a New York-based law firm. Mr. Beinstein is a certified public accountant in New York and New Jersey and prior to joining Proskauer was a partner and national director of finance and administration at Coopers & Lybrand. Mr. Beinstein previously served as a director of New Valley Corporation. Mr. Beinsteins pertinent experience, qualifications, attributes and skills include financial literacy and expertise, managerial experience through his years at Coopers & Lybrand, Proskauer Rose LLP, Milbank, Tweed, Hadley & McCloy LLP and Schulte Roth & Zabel LLP, and the knowledge and experience he has attained through his service as a director of ours and other publicly traded corporations. | |
Robert J. Eide, 57
Director since 2001 |
Mr. Eide has been the chairman and chief executive officer of Aegis Capital Corp., a broker-dealer and a FINRA member firm, since 1984. Mr. Eide also serves as a director of Nathans Famous, Inc., a chain of fast food restaurants, and Vector Group. Mr. Eide has been a member of the New York State Bar Association since 1979. Mr. Eides pertinent experience, qualifications, attributes and skills include financial literacy and expertise, industry knowledge, managerial experience, and the knowledge and experience he has attained through his service as a director of publicly-traded corporations. |
4
Phillip Frost, M.D., 73
Director since 2004 |
Dr. Frost has served as chairman of our board of directors since July 2006. He also served as a member of our board of directors from May 2001 until July 2002. In March 2010, Dr. Frost was named chairman of the board of Teva Pharmaceutical Industries Ltd., a pharmaceutical company, and had previously served as vice chairman of the board of directors since January 2006. Since March 2007, he has served as chairman of the board and chief executive officer of OPKO Health, Inc., a specialty healthcare company focused on the development of agents for ophthalmic disease and diagnostic imaging systems that complement OPKOs therapeutic products. From 1972 to 1990, Dr. Frost was the chairman of the Department of Dermatology at Mt. Sinai Medical Center of Greater Miami, Miami Beach, Florida. From 1972 to 1986, Dr. Frost was chairman of the board of directors of Key Pharmaceuticals, Inc., and from 1987 to January 2006, he served as chairman of the board of directors and chief executive officer of IVAX Corporation. Dr. Frost also serves as chairman of the board of directors of PROLOR Biotech, Inc., a development stage biopharmaceutical company. Dr. Frost is a currently a director of Continucare Corporation, a provider of outpatient healthcare services, and Castle Brands Inc. He also serves as Chairman of Temple Emanu-El, as a member of the Board of Regents of the Smithsonian Institution, as a director of the Florida Council of 100 and as a trustee of each of the University of Miami, the Scripps Research Institute, the Miami Jewish Home for the Aged, and the Mount Sinai Medical Center. Dr. Frost previously served as a director for Northrop Grumman Corp., Ideation Acquisition Corp., Protalix Bio Therapeutics, Inc., and Cellular Technical Services Company, Inc. (now SafeStitch Medical, Inc.), as chairman of Ivax Diagnostics, Inc. and as governor and co-vice-chairman of the American Stock Exchange (now NYSE Amex). Dr. Frosts pertinent experience, qualifications, attributes and skills include financial literacy and expertise, industry knowledge, managerial experience, and the knowledge and experience he has attained through his service as a director of publicly-traded corporations. | |
Brian S. Genson, 61
Director since 2004 |
Mr. Genson has been president of Pole Position Investments, a company engaged in the motor sport business, since 1989. Mr. Genson also serves as a managing director of F1Collectors.com and F1 Action located in Buntingford, England, which is engaged in investing in the motor sport industry. Mr. Genson was also responsible for introducing Ben and Jerrys Ice Cream Company to the Japanese market. Mr. Genson also serves as a director of Nathans Famous. Mr. Gensons pertinent experience, qualifications, attributes and skills include managerial experience and experience he has attained through his service as a director of publicly-traded corporations. | |
Saul Gilinski, 55 Director since 2006 |
Mr. Gilinski has served as president and a director of Osmopharm S.A., a Swiss-based manufacturer of modified release pharmaceutical active ingredients, since 1999. He has served as the chairman of C.I. Farmacapsulas S.A., a manufacturer of pharmaceutical capsules, since 1985. Since December 2003, Mr. Gilinski has served as chairman of Capscanada Corporation, a Canada-based manufacturer of pharmaceutical capsules. Since 1994, he has served as chairman of Ajix, Inc., a distribution import/export company. He is also a director of Premier Commercial Realty, Inc., a commercial property developer in South Florida. Mr. Gilinskis pertinent experience, qualifications, attributes and skills include financial literacy and expertise and managerial experience. | |
Dr. Richard M. Krasno, 68
Director since 2006 |
Dr. Krasno has served as the executive director of the William R. Kenan, Jr. Charitable Trust and as president of the four affiliated William R. Kenan, Jr. Funds since October 1999. Prior to joining the Trust, Dr. Krasno was the president of the Monterey Institute of International Studies in Monterey, California. From 1981 to 1998, he served as president and chief executive officer of the Institute of International Education in New York. He also served as Deputy Assistant Secretary of Education in Washington, D.C. from 1979 to 1980. Dr. Krasno previously served as a director of IVAX Corporation. Dr. Krasnos pertinent experience, qualifications, attributes and skills include financial literacy and expertise and managerial experience. | |
Richard J. Lampen, 56
Director since 2002 |
Mr. Lampen has been our president and chief executive officer since September 2006. Since July 1996, Mr. Lampen has served as executive vice president of Vector Group. Since October 2008, Mr. Lampen has served as interim president and chief executive officer and a director of Castle Brands Inc. From October 1995 to December 2005, Mr. Lampen served as the executive vice president and general counsel of New Valley, where he also served as a member of its board of directors. Since January 1997, Mr. Lampen has served as a director of CDSI Holdings Inc., an affiliate of New Valley seeking acquisitions or investments, and since November 1998 has been its president and chief executive officer. From May 1992 to September 1995, Mr. Lampen was a partner at Steel Hector & Davis, a law firm in Miami, Florida. From January 1991 to April 1992, Mr. Lampen was a managing director at Salomon Brothers Inc, an investment bank, and was an employee at Salomon Brothers from 1986 to April 1992. Mr. Lampen has served as a director of a number of other companies, including U.S. Can Corporation, The International Bank of Miami, N.A. and Specs Music Inc., as well as a court-appointed independent director of Trump Plaza Funding, Inc. Mr. Lampens pertinent experience, qualifications, attributes and skills include his knowledge and experience in our company attained through his service as a director of our company since 2002 and as president and chief executive officer since 2006, his industry experience, his managerial experience and the knowledge and experience he has attained through his service as a director of publicly-traded corporations. |
5
Howard M. Lorber, 61
Director since 2001 |
Mr. Lorber has been vice chairman of our board of directors since July 2006. Previously, Mr. Lorber had been chairman of our board of directors from May 2001 to July 2006. Mr. Lorber has been president and chief executive officer of Vector Group since January 2006 and has served as a director of Vector Group since January 2001. He served as president and chief operating officer of Vector Group from January 2001 to December 2005. From November 1994 to December 2005, Mr. Lorber served as president and chief operating officer of New Valley, where he also served as a director. Mr. Lorber was chairman of the board of directors of Hallman & Lorber Assoc. Inc., consultants and actuaries of qualified pension and profit sharing plans, and various of its affiliates from 1975 to December 2004 and has been a consultant to these entities since January 2005; chief executive officer from November 1993 to December 2006 and executive chairman of the board of directors since January 2007 of Nathans Famous; and a director of United Capital Corp., a real estate investment and diversified manufacturing company, since May 1991. Mr. Lorber previously served as a director of SP Acquisition Holdings, Inc. He is also a trustee of Long Island University. Mr. Lorbers pertinent experience, qualifications, attributes and skills include managerial experience, industry knowledge, financial literacy and the knowledge and experience he has attained through his service as a director and chief executive officer of publicly-traded corporations. | |
Jeffrey S. Podell, 69
Director since 2004 |
Mr. Podell has been the chairman of the board and president of Newsote, Inc., a privately-held holding company, since 1989. He also serves as a director of Vector Group. Mr. Podell was a member of the New York State Bar Association from 1965 until March 2010. Mr. Podells pertinent experience, qualifications, attributes and skills include managerial experience, financial literacy and the knowledge and experience he has attained through his service as a director of publicly-traded corporations. | |
Richard J. Rosenstock, 57
Director since 1999 |
From May 2001 until December 2002, Mr. Rosenstock served as vice chairman of our board of directors and from August 1999 until December 2002, served as our chief operating officer. He also served as our president from August 1999 until May 2001. Since January 2003, Mr. Rosenstock has been a registered representative of Ladenburg Thalmann & Co. Inc., one of our broker-dealer subsidiaries. Mr. Rosenstock was affiliated with Ladenburg Capital Management Inc., one of our subsidiaries, from 1986 until December 2002, serving from May 2001 as Ladenburg Capital Managements chief executive officer. From January 1994 until May 1998, he served as an executive vice president of Ladenburg Capital Management and was its president from May 1998 until November 2001. Mr. Rosenstocks pertinent experience, qualifications, attributes and skills include his industry knowledge and the experience he has attained through his service as a director of a publicly-traded corporation. | |
Mark Zeitchick, 45 Director since 1999 |
Mr. Zeitchick has been our executive vice president since September 2006. From August 1999 until December 2003, Mr. Zeitchick served as one of our executive vice presidents. Mr. Zeitchick has also been president and chief executive officer of Ladenburg Thalmann & Co. Inc. since September 2006 and a registered representative with Ladenburg Thalmann & Co. Inc. since March 2001. Mr. Zeitchick has been Ladenburg Capital Managements co-chairman since November 2001. From September 1995 until November 2001, he was an executive vice president of Ladenburg Capital Management. From May 2001 until November 2001, he served as chairman of Ladenburg Capital Management, and became co-chairman in November 2001. Mr. Zeitchicks pertinent experience, qualifications, attributes and skills include managerial experience, industry knowledge and the knowledge and experience he has attained through his service as a director of a publicly-traded corporation. |
6
| reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the board whether the audited financial statements should be included in our Form 10-K; | ||
| discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements; |
7
| discussing with management and the independent auditor the effect on our financial statements of (i) regulatory and accounting initiatives and (ii) off-balance sheet structures; | ||
| discussing with management major financial risk exposures and the steps management has taken to monitor and control such exposures, including our risk assessment and risk management policies; | ||
| reviewing disclosures made to the audit committee by our chief executive officer and chief financial officer during their certification process for our Form 10-K and Form 10-Q about any significant deficiencies in the design or operation of internal controls or material weaknesses therein and any fraud involving management or other employees who have a significant role in our internal controls; | ||
| verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law; | ||
| reviewing and approving all related-party transactions; | ||
| inquiring and discussing with management our compliance with applicable laws and regulations; | ||
| pre-approving all auditing services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed; | ||
| appointing or replacing the independent auditor; | ||
| determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work; and | ||
| establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies. |
ITEM 11. | EXECUTIVE COMPENSATION. |
| establishing the general compensation policy for our executive officers, including our chief executive officer; | ||
| administering our Qualified Employee Stock Purchase Plan (QESPP), our Amended and Restated 1999 Performance Equity Plan (1999 Plan) and our 2009 Incentive Compensation Plan (2009 Plan); | ||
| determining who participates in these plans, establishing performance goals, if any, and determining specific grants and awards to the participants. |
8
| a base salary, which is not anticipated to be the sole component of total annual cash compensation; | ||
| brokerage commissions, if the executive is a registered representative, with respect to customer accounts for which such executive is the designated account representative; | ||
| a discretionary cash bonus; and | ||
| a stock option grant. |
9
10
Non-Equity | ||||||||||||||||||||||||||||
Option | Incentive Plan | All Other | ||||||||||||||||||||||||||
Fiscal | Salary | Bonus | Awards | Compensation | Compensation | Total | ||||||||||||||||||||||
Name and Principal Position | Period | ($) | ($) | ($)(1) | ($) | ($) | ($) | |||||||||||||||||||||
Richard J. Lampen, | 2009 | | | | | | | |||||||||||||||||||||
chief executive
officer and
|
2008 | | 150,000 | 591,480 | | | 741,480 | |||||||||||||||||||||
president
(2) |
||||||||||||||||||||||||||||
Mark Zeitchick, executive vice | 2009 | 250,000 | 100,000 | | | 205,929 | (3) | 555,929 | ||||||||||||||||||||
president; president
and |
2008 | 250,000 | 150,000 | 591,480 | | 464,089 | (3) | 1,455,569 | ||||||||||||||||||||
chief executive
officer of |
||||||||||||||||||||||||||||
Ladenburg Thalmann & Co. |
||||||||||||||||||||||||||||
Inc. |
||||||||||||||||||||||||||||
Brett H. Kaufman, vice | 2009 | 200,000 | 100,000 | | | | 300,000 | |||||||||||||||||||||
president and
chief
|
2008 | (4) | 154,616 | 100,000 | 226,635 | | 54,116 | (5) | 535,367 | |||||||||||||||||||
financial officer |
||||||||||||||||||||||||||||
(1) | Represents the aggregate grant date fair value of stock options granted for the year ended December 31, 2008 as determined in accordance with FASB ASC Topic 718, rather than an amount paid to or realized by the named executive officer. Assumptions used in the calculation of such amount are included in note 15 to our audited financial statements for the year ended December 31, 2009 included in our Original 10-K. The FASB ASC Topic 718 amounts from these grants may never be realized by the named executive officer. | |
(2) | Does not include payments to Vector Group under the management services agreement with Vector Group described under the caption Compensation Arrangements for Executive Officers below. | |
(3) | Represents commissions earned from customer accounts for which the individual is a designated account representative ($199,031 in 2009 and $457,209 in 2008) and health and dental insurance premiums paid by us. | |
(4) | Mr. Kaufman became a vice president in March 2008 and became our chief financial officer in April 2008. | |
(5) | Represents relocation expenses ($13,359), brokerage, legal and other fees in connection with the sale of his house in New York ($30,635) and legal fees in connection with the negotiation of his employment letter with us ($10,122). |
11
Option Awards | ||||||||||||||||||||
Equity | ||||||||||||||||||||
Incentive Plan | ||||||||||||||||||||
Awards: | ||||||||||||||||||||
Number of | Number of | Number of | ||||||||||||||||||
Securities | Securities | Securities | ||||||||||||||||||
Underlying | Underlying | Underlying | Option | |||||||||||||||||
Unexercised | Unexercised | Unexercised | Exercise | |||||||||||||||||
Options (#) | Options (#) | Unearned | Price | Option | ||||||||||||||||
Name | Exercisable | Unexercisable | Options (#) | ($) | Expiration Date | |||||||||||||||
Richard J. Lampen |
20,000 | 0 | | 0.88 | 01/09/2012 | |||||||||||||||
20,000 | 0 | 0.22 | 11/14/2012 | |||||||||||||||||
20,000 | 0 | 0.30 | 09/16/2013 | |||||||||||||||||
20,000 | 0 | 0.48 | 03/02/2015 | |||||||||||||||||
450,000 | 150,000 | (1) | 0.88 | 07/17/2016 | ||||||||||||||||
20,000 | 0 | 1.39 | 11/05/2016 | |||||||||||||||||
20,000 | 0 | 2.30 | 06/28/2017 | |||||||||||||||||
300,000 | 300,000 | (2) | 2.30 | 07/25/2017 | ||||||||||||||||
150,000 | 450,000 | (3) | 1.58 | 10/30/2018 | ||||||||||||||||
Mark Zeitchick |
0 | 0 | | 4.0625 | 08/23/2009 | |||||||||||||||
250,000 | 0 | 0.88 | 01/09/2012 | |||||||||||||||||
125,000 | 0 | 1.01 | 05/25/2014 | |||||||||||||||||
150,000 | 0 | 0.58 | 08/17/2015 | |||||||||||||||||
450,000 | 150,000 | (1) | 0.88 | 07/17/2016 | ||||||||||||||||
300,000 | 300,000 | (2) | 2.30 | 07/25/2017 | ||||||||||||||||
150,000 | 450,000 | (3) | 1.58 | 10/30/2018 | ||||||||||||||||
Brett H. Kaufman |
37,500 | 112,500 | (4) | | 2.30 | 03/24/2018 |
(1) | These options vest July 17, 2010. | |
(2) | These options vest in two equal annual installments beginning on July 25, 2010. | |
(3) | These options vest in three equal installments beginning on October 30, 2010. | |
(4) | These options vest in three equal annual installments beginning on March 25, 2010. |
12
| Cause means: (i) conviction of, or the entry of a plea of guilty or nolo contendere to, a felony, (ii) alcoholism or drug addiction which materially impairs Mr. Kaufmans ability to perform his duties, (iii) continued, intentional and willful failure to substantially and materially perform his material duties and responsibilities after receipt of written notice and failure to cure within 30 days of such notice, (iv) willful and deliberate misconduct that results, or is reasonably likely to result, in material and demonstrative harm to us or our subsidiaries or affiliates, or (v) substantial impairment from performing his duties for a period of longer than 60 consecutive days or more than 120 days as a result of an action taken by a regulatory body or self-regulatory agency. | ||
| Disability means that Mr. Kaufman, as a result of incapacity due to physical or mental illness, has been substantially unable to perform his normal duties for an entire period of six consecutive months, and has not returned to the substantial performance of his duties on a full-time basis within 30 days after written notice of termination is given by us after such six-month period. | ||
| Good Reason means: (i) a material diminution in duties or responsibilities, (ii) failure to appoint or elect Mr. Kaufman as our vice president and chief financial officer or his removal from such position, (iii) a reduction in his base salary, (iv) relocation of his office to a location outside of Miami, FL (other than in connection with travel necessary to perform his duties), or (v) a material breach by us of his employment letter, an indemnification agreement between us or any equity agreement between us, including, without limitation, the failure of any successor to all or substantially all of our assets to assume our obligations under the employment letter and the indemnification agreement. |
13
Change-in-Control | Death | Disability | ||||||||||
Name | ($) | ($) | ($) | |||||||||
Richard J. Lampen |
| | | |||||||||
Mark Zeitchick |
2,250 | 2,250 | 2,250 | |||||||||
Brett H. Kaufman |
| | |
Fees Earned or | Stock | Option | ||||||||||||||
Paid in Cash | Awards | Awards(1) | Total | |||||||||||||
Name | ($) | ($) | ($) | ($) | ||||||||||||
Henry C. Beinstein |
46,500 | | 10,850 | 57,350 | ||||||||||||
Robert J. Eide |
46,500 | | 10,850 | 57,350 | ||||||||||||
Phillip Frost, M.D. |
123,000 | | 10,850 | 133,850 | ||||||||||||
Brian S. Genson |
29,000 | | 10,850 | 39,850 | ||||||||||||
Saul Gilinski |
33,500 | | 10,850 | 44,350 | ||||||||||||
Howard M. Lorber |
24,000 | | 10,850 | 34,850 | ||||||||||||
Dr. Richard M. Krasno |
34,500 | | 10,850 | 45,350 | ||||||||||||
Jeffrey S. Podell |
36,000 | | 10,850 | 46,850 |
(1) | Represents the aggregate grant date fair value of stock options granted for the year ended December 31, 2009 as determined in accordance with FASB ASC Topic 718, rather than an amount paid to or realized by the director. Assumptions used in the calculation of such amount are included in note 15 to our audited financial statements for the year ended December 31, 2009 included in our Original 10-K. The FASB ASC Topic 718 amounts from these grants may never be realized. The aggregate number of outstanding option awards at December 31, 2009 was as follows: |
Name | Aggregate Number of Option Awards | |||
Henry C. Beinstein |
160,000 | |||
Robert J. Eide |
100,000 | |||
Phillip Frost, M.D. |
3,120,000 | |||
Brian S. Genson |
100,000 | |||
Saul Gilinski |
80,000 | |||
Howard M. Lorber |
1,060,000 | |||
Dr. Richard M. Krasno |
80,000 | |||
Jeffrey S. Podell |
100,000 |
14
| those persons or groups known to beneficially own more than 5% of our common stock, | ||
| each of our directors, | ||
| each executive officer named in the Summary Compensation Table above and | ||
| all directors and executive officers as a group. |
Beneficial ownership of our common stock | ||||||||
Number of | ||||||||
Name and Address of Beneficial Owner | Shares | Percent | ||||||
Phillip Frost, M.D. and related entities |
56,447,130 | (1) | 32.88 | % | ||||
4400 Biscayne Boulevard, 15th Floor
Miami, Florida 33137 |
||||||||
New Valley LLC |
13,891,205 | (2) | 8.27 | % | ||||
100 S.E. Second Street Miami, FL 33131 |
||||||||
Howard M. Lorber |
3,781,674 | (3) | 2.24 | % | ||||
Richard J. Rosenstock |
3,199,670 | (4) | 1.90 | % | ||||
Mark Zeitchick |
3,157,900 | (5) | 1.86 | % | ||||
Richard J. Lampen |
1,593,631 | (6) | * | |||||
Saul Gilinski |
1,073,600 | (7) | * | |||||
Dr. Richard M. Krasno |
275,500 | (8) | * | |||||
Henry C. Beinstein |
162,835 | (9) | * | |||||
Robert J. Eide |
154,386 | (10) | * | |||||
Jeffrey S. Podell |
122,013 | (11) | * | |||||
Brian S. Genson |
110,000 | (12) | * | |||||
Brett H. Kaufman |
90,000 | (13) | * | |||||
All directors and executive officers as a group (12 persons) |
84,059,544 | (14) | 41.77 | % |
* | Less than 1 percent. | |
(1) | Represents (i) 9,683,699 shares of common stock held by Frost Gamma Investments Trust, a trust organized under Florida law (Gamma Trust), (ii) 43,013,431 shares of common stock held by Frost-Nevada Investments Trust (Nevada Trust), a trust organized under Florida law, (iii) 1,750,000 shares of common stock issuable upon exercise of currently exercisable |
15
options held by Dr. Frost and (iv) 2,000,000 shares of Common Stock issuable upon exercise of currently exercisable warrants held by Nevada Trust. Dr. Frost is the sole trustee of both Gamma Trust and Nevada Trust. As the sole trustee of Gamma Trust and Nevada Trust, Dr. Frost may be deemed the beneficial owner of all shares owned by Gamma Trust and Nevada Trust, respectively, by virtue of his power to vote or direct the vote of such shares or to dispose or direct the disposition of such shares owned by such trusts. Accordingly, solely for purposes of reporting beneficial ownership of such shares pursuant to Section 13(d) of the Securities Exchange Act of 1934, each of Dr. Frost, Gamma Trust and Nevada Trust will be deemed to be the beneficial owner of the shares held by any other such person. The foregoing information was derived from a Schedule 13D filed with the SEC on December 9, 1997, as amended, as well as from information made known to us. | ||
(2) | New Valley LLC is wholly-owned by Vector Group Ltd. | |
(3) | Represents (i) 2,669,580 shares of common stock held directly by Mr. Lorber, (ii) 301,227 shares of common stock held by Lorber Epsilon 1999 Limited Partnership, a Delaware limited partnership, (iii) 220,800 shares of common stock held by Lorber Alpha II Limited Partnership, a Nevada limited partnership, (iv) 590,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Lorber and (v) 67 shares of common stock held of record by Citibank N.A. as custodian for the benefit of Howard Lorber Rollover IRA. Mr. Lorber indirectly exercises sole voting power and sole dispositive power over the shares of common stock held by the partnerships. Lorber Epsilon 1999 LLC, a Delaware limited liability company, is the general partner of Lorber Epsilon 1999 Limited Partnership. Lorber Alpha II Limited Partnership is the sole member of, and Mr. Lorber is the manager of, Lorber Epsilon 1999 LLC. Lorber Alpha II, Inc., a Nevada corporation, is the general partner of Lorber Alpha II Limited Partnership. Mr. Lorber is the director, officer and principal stockholder of Lorber Alpha II, Inc. Does not include (i) the shares of common stock beneficially owned by New Valley LLC, of which Mr. Lorber serves as an executive officer and director of its parent, Vector Group Ltd., and (ii) 590,824 shares of common stock held by the Lorber Charitable Fund, a New York not-for-profit corporation, of which family members of Mr. Lorber serve as directors and executive officers. | |
(4) | Represents (i) 243,562 shares of common stock held directly by Mr. Rosenstock, (ii) 2,286,346 shares of common stock held of record by The Richard J. Rosenstock Revocable Living Trust Dated 3/5/96, of which Mr. Rosenstock is the sole trustee and beneficiary, (iii) 50,000 shares of common stock held of record by the NFS/FMTC Rollover IRA for the benefit of Richard J. Rosenstock, (iv) 5,000 shares of common stock held of record by the NFS/FMTC IRA for the benefit of Roni L. Rosenstock, Mr. Rosenstocks wife, (v) 5,000 shares of common stock held of record by the NFS/FMTC IRA for the benefit of Richard J. Rosenstock ,(vi) 280,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Rosenstock and (vii) 329,762 shares of common stock issuable upon exercise of currently exercisable warrants held by Roni L. Rosenstock. | |
(5) | Includes (i) 1,732,900 shares of common stock held of record by MZ Trading LLC, of which Mr. Zeitchick is the sole managing member, (ii) 1,275,000 shares of common stock issuable upon exercise of currently exercisable options held by MZ Trading and (iii)150,000 shares of common stock issuable upon exercise of currently exercisable options held by Mark Zeitchick. | |
(6) | Includes 1,020,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Lampen. Does not include the shares of common stock beneficially owned by New Valley LLC, of which Mr. Lampen serves as an executive officer of its parent, Vector Group Ltd. | |
(7) | Includes 60,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Gilinski. | |
(8) | Includes 60,000 shares of common stock issuable upon exercise of currently exercisable options held by Dr. Krasno. | |
(9) | Includes (i) 1,532 shares of common stock held of record in the individual retirement account of Mr. Beinsteins spouse and (ii) 140,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Beinstein. | |
(10) | Includes 80,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Eide. | |
(11) | Includes 80,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Podell. | |
(12) | Includes 80,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Genson. |
16
(13) | Includes 75,000 shares of common stock issuable upon exercise of currently exercisable options held by Mr. Kaufman. | |
(14) | Includes 7,969,762 shares of common stock issuable upon exercise of currently exercisable options and warrants. |
Number of Securities | ||||||||||||
Remaining Available for | ||||||||||||
Future Issuance Under | ||||||||||||
Number of Securities | Weighted-Average | Equity Compensation | ||||||||||
to be Issued Upon | Exercise Price of | Plans | ||||||||||
Exercise of | Outstanding | (Excluding Securities | ||||||||||
Outstanding Options, | Options, Warrants | Reflected in the First | ||||||||||
Plan Category | Warrants and Rights | and Rights | Column) | |||||||||
Equity
compensation plans
approved by
security holders |
15,257,290 | $ | 1.46 | 30,042,154 | (1) | |||||||
Equity compensation
plans not approved
by security holders |
12,664,000 | (2)(3)(4)(5)(6) | $ | 1.27 | | |||||||
(1) | Consists of approximately 5,182,154 million shares available for future issuance under our 1999 Plan and 24,860,000 under the 2009 Plan. | |
(2) | Includes warrants to purchase 2,900,000 shares of our common stock at $0.96 per share, issued to acquire Capitalink, L.C. | |
(3) | Includes warrants to purchase 1,500,000 shares of our common stock at $0.94 per share, issued to acquire Broadwall Capital LLC. | |
(4) | Includes warrants to purchase 500,000 shares of our common stock at $0.95 per share, which we issued to acquire a 10% interest in the Florida Value Fund. | |
(5) | Includes warrants to purchase 2,000,000 shares of our common stock at $1.91 per share, issued to an affiliate of our chairman of the board and our principal shareholder, under a credit agreement in connection with the Investacorp acquisition. | |
(6) | Includes non-plan options described below. |
17
| the aggregate amount involved is expected to exceed $120,000 in any calendar year; | ||
| we or any of our subsidiaries is a participant; and | ||
| any (a) executive officer, director or director nominee, (b) five percent or greater beneficial owner of our common stock, or (c) immediate family member, of the persons listed in clauses (a) and (b), has or will have a material interest (other than solely as a result of being a director or a less than 10 percent beneficial owner of another entity). |
| whether the transaction is on terms no less favorable to us than terms generally available to us from an unaffiliated third-party under the same or similar circumstances; and | ||
| the extent of the related partys interest in the transaction. |
18
2009 | 2008 | |||||||
(in thousands) | ||||||||
Audit fees |
$ | 720 | $ | 714 | ||||
Audit-Related fees |
| 27 | ||||||
Tax fees |
| 17 | ||||||
All other fees |
106 | 80 | ||||||
Total fees |
$ | 826 | $ | 838 |
19
Incorporated | ||||||||
By Reference | ||||||||
from | No. in | |||||||
Exhibit No. | Description | Document | Document | |||||
3.1
|
Articles of Incorporation | A | 3.1 | |||||
3.2
|
Articles of Amendment to the Articles of Incorporation, dated August 24, 1999 | B | 3.2 | |||||
3.3
|
Articles of Amendment to the Articles of Incorporation, dated April 3, 2006 | C | 3.1 | |||||
3.4
|
Amended and Restated Bylaws | D | 3.2 | |||||
4.1
|
Form of common stock certificate | A | 4.1 | |||||
4.2
|
Credit Agreement, dated as of October 19, 2007, by and between the Company and Frost Gamma Investments Trust, including the form of note thereto | E | 4.1 | |||||
4.3
|
Amendment No. 1 to Credit Agreement by and between the Company and Frost Nevada Investments Trust, as assignee, dated as of August 25, 2009 | V | 4.2 | |||||
4.4
|
Forgivable Loan Agreement, dated as of August 25, 2009, between the Company and National Financial Services LLC. Certain Portions of this agreement have been omitted under a request for confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 and filed separately with the United States Securities and Exchange Commission. | V | 4.1 | |||||
4.5
|
Non-Negotiable Promissory Note, dated as of October 19, 2007, made by the Company in favor of Bruce A. Zwigard | E | 4.2 | |||||
4.6
|
Pledge Agreement, dated as of October 19, 2007, by and between the Company and Bruce A. Zwigard | E | 4.3 | |||||
4.7
|
Non-Negotiable Promissory Note, dated as of August 13, 2008, made by Ladenburg Thalmann Financial Services Inc. in favor of Mark C. Mettelman and Robert W. Bruderman as representatives of the shareholders of Triad Advisors, Inc. | U | 4.1 | |||||
4.8
|
Pledge Agreement, dated as of August 13, 2008, by and between Ladenburg Thalmann Financial Services Inc. and Mark C. Mettelman and Robert W. Bruderman as representatives of the shareholders of Triad Advisors, Inc. | U | 4.2 | |||||
10.1
|
Amended and Restated 1999 Performance Equity Plan* | F | 4.1 | |||||
10.2
|
2009 Incentive Compensation Plan.* | W | Exhibit A | |||||
10.3
|
Form of Stock Option Agreement, dated as of May 7, 2001, between the Company and certain directors* | G | 10.3 | |||||
10.4
|
Schedule of Stock Option Agreements in the form of Exhibit 10.3, including material detail in which such documents differ from Exhibit 10.3* | G | 10.3.1 | |||||
10.5
|
Stock Option Agreement, dated as of January 10, 2002, between the Company and Richard J. Lampen* | H | 10.2 |
20
Incorporated | ||||||||
By Reference | ||||||||
from | No. in | |||||||
Exhibit No. | Description | Document | Document | |||||
10.6
|
Form of Stock Option Agreement, dated January 10, 2002, between the Company and each of Richard J. Rosenstock and Mark Zeitchick* | H | 10.3 | |||||
10.7
|
Schedule of Stock Option Agreements in the form of Exhibit 10.6, including material detail in which such documents differ from Exhibit 10.6* | H | 10.3.1 | |||||
10.8
|
Ladenburg Thalmann Financial Services Inc. Qualified Employee Stock Purchase Plan* | I | Exhibit A | |||||
10.9
|
Form of Stock Option Agreement, dated November 15, 2002, between the Company and each of Bennett S. LeBow, Howard M. Lorber, Henry C. Beinstein, Robert J. Eide and Richard J. Lampen* | J | 10.48 | |||||
10.10
|
Schedule of Stock Option Agreements in the form of Exhibit 10.9, including material detail in which such documents differ from Exhibit 10.9* | J | 10.48.1 | |||||
10.11
|
Form of Stock Option Agreement, dated September 17, 2003, between the Company and each of Howard M. Lorber, Henry C. Beinstein and Richard J. Lampen* | K | 10.1 | |||||
10.12
|
Schedule of Stock Option Agreements in the form of Exhibit 10.11, including material detail in which such documents differ from Exhibit 10.11* | K | 10.1.1 | |||||
10.13
|
Office Lease dated March 30, 2007 between the Company and Frost Real Estate Holdings, LLC | L | 10.1 | |||||
10.14
|
Stock Option Agreement, dated July 13, 2006, issued to Dr. Phillip Frost* | M | 10.2 | |||||
10.15
|
Warrant issued to BroadWall Capital LLC | N | 10.1 | |||||
10.16
|
Form of Stock Option Agreement issued to employees of BroadWall | N | 10.2 | |||||
10.17
|
Letter Agreement, dated September 14, 2006, between Ladenburg Thalmann Financial Services Inc. and Vector Group Ltd. (Vector Agreement) | O | 10.1 | |||||
10.18
|
First Amendment to Vector Agreement dated as of December 20, 2007 | P | 10.1 | |||||
10.19
|
Form of Warrant issued to the stockholders of Telluride Holdings, Inc. | Q | 10.2 | |||||
10.20
|
Amendment to Employment Agreement between Ladenburg Thalmann Financial Services Inc., Ladenburg Thalmann & Co. Inc. and Mark Zeitchick.* | R | 10.3 | |||||
10.21
|
Stock Purchase Agreement, dated as of October 19, 2007, by and among Ladenburg Thalmann Financial Services Inc., the Investacorp Companies, the VIA Companies, Bruce A. Zwigard and the Bruce A. Zwigard Grantor Retained Annuity Trust dated June 20, 2007 | E | 10.1 | |||||
10.22
|
Non-Plan Option Agreement, dated as of October 19, 2007, by and between Ladenburg Thalmann Financial Services Inc. and Bruce A. Zwigard | E | 10.2 | |||||
10.23
|
Warrant, dated as of October 19, 2007, issued to Frost Gamma Investments Trust pursuant to Credit Agreement | E | 10.3 | |||||
10.24
|
Employment Letter dated as of February 8, 2008 between Ladenburg Thalmann Financial Services Inc. and Brett Kaufman* | S | 10.1 | |||||
10.25
|
Agreement and Plan of Merger dated as of July 9, 2008 by and among Ladenburg Thalmann Financial Services Inc., Triple Acquisition Inc., Triad Advisors, Inc. and the shareholders of Triad Advisors, Inc. | T | 2.1 | |||||
21
|
List of Subsidiaries | X | 21 | |||||
23.1
|
Consent of Eisner LLP | X | 23.1 | |||||
24
|
Power of Attorney | X | Signature Page | |||||
31.1
|
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ** | | |||||
31.2
|
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ** | | |||||
32.1
|
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | | |||||
32.2
|
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ** | |
* | Management Compensation Contract | |
** | Filed herewith |
21
A. | Registration statement on Form SB-2 (File No. 333-31001). | |
B. | Annual report on Form 10-K for the year ended August 24, 1999. | |
C. | Quarterly report on Form 10-Q for the quarter ended June 30, 2006. | |
D. | Current report on Form 8-K, dated September 20, 2007 and filed with the SEC on September 21, 2007. | |
E. | Current report on Form 8-K, dated October 19, 2007 and filed with the SEC on October 22, 2007. | |
F. | Registration statement on Form S-8 (File No. 333-139254). | |
G. | Quarterly report on Form 10-Q for the quarter ended June 30, 2001. | |
H. | Registration statement on Form S-3 (File No. 333-81964). | |
I. | Definitive proxy statement filed with the SEC on October 3, 2002 relating to the annual meeting of shareholders held on November 6, 2002. | |
J. | Annual report on Form 10-K for the year ended December 31, 2002. | |
K. | Quarterly report on Form 10-Q for the quarter ended September 30, 2003. | |
L. | Current report on Form 8-K, dated March 30, 2007 and filed with the SEC on April 2, 2007. | |
M. | Current report on Form 8-K, dated July 10, 2006 and filed with the SEC on August 3, 2006. | |
N. | Current report on Form 8-K, dated September 11, 2006 and filed with the SEC on September 12, 2006. | |
O. | Current report on Form 8-K, dated September 21, 2006 and filed with the SEC on September 27, 2006. | |
P. | Current report on Form 8-K, dated December 20, 2007 and filed with the SEC on December 20, 2007. | |
Q. | Current report on Form 8-K, dated September 6, 2006 and filed with the SEC on September 7, 2006. | |
R. | Current report on Form 8-K/A dated September 6, 2006 and filed with the SEC on October 24, 2006. | |
S. | Current report on Form 8-K, dated March 27, 2008 and filed with the SEC on March 28, 2008. | |
T. | Current report on Form 8-K, dated July 9, 2008 and filed with the SEC on July 10, 2008. | |
U. | Current report on Form 8-K, dated August 13, 2008 and filed with the SEC on August 14, 2008. | |
V. | Quarterly report on Form 10-Q for the quarter ended September 30, 1009. | |
W. | Definitive proxy statement filed with the SEC on July 20, 2009 relating to the annual meeting of shareholders held on August 27, 2009. | |
X. | Annual report on Form 10-K for the year ended December 31, 2009. |
22
LADENBURG THALMANN FINANCIAL SERVICES INC. (Registrant) Dated: April 30, 2010 |
||||
By: | /s/ Brett H. Kaufman | |||
Name: | Brett H. Kaufman | |||
Title: | Vice President and Chief Financial Officer | |||
23